Search Results 811-820 of 1532 for immunosuppressant drugs

  1. Mark R. Litzow, M.D. - Doctors and Medical Staff - Mayo Clinic

    Litzow is Professor of Medicine in the Division of Hematology at Mayo Clinic. He was the Director of the BMT Program at Mayo from 1992 to 2008 and continues to ...

  2. Publications - Benjamin H. Eidelman, M.D. - Mayo Clinic

    Neurological complications of immunosuppressive agents. Gastroenterology. 1999; 12(4):128-34. Small SL, Fukui MB, Bramblett GT, Eidelman BH. Immunosuppression- ...

  3. Jacob J. Orme, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    They have gone on to develop novel treatments that help prevent the activity of sPD-L1 and other immunosuppressants to rescue cancer immunotherapy in multiple ...

  4. Pancreas transplant - Doctors & Departments - Mayo Clinic

    Drugs & Supplements · Healthy Lifestyle · Mayo Clinic ... https://www.kidney.org/atoz/content/immunosuppression ... Pancreas-kidney transplantation in diabetes ...

  5. Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... immunosuppressive medications within 14 days of study drug administration.

  6. A Study To Evaluate The Effectiveness And Safety Of RAd-IFN Administered With Celecoxib And Gemcitabine In Patients With Malignant Pleural Mesothelioma - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... College of Medicine and Science ... Patients with active, known, or suspected auto-immune disease or a syndrome ...

  7. Breast and Melanoma Surgical Oncology in Rochester - Clinical trials

    Currently, most drug-related cancer care is conducted in clinic type centers or hospitals which may isolate patients from family, friends and familiar ...

  8. Safety And Tolerability Of Atezolizumab (ATZ) In Combination With Radium-223 Dichloride (R-223-D) In Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With An Androgen Pathway Inhibitor - Mayo Clinic

    Immunostimulants within 4 weeks or immunosuppressants within 14 days prior to study drug; Prior radium-223 dichloride or hemibody external radiotherapy ...

  9. Breast cancer treatment Archives - Mayo Clinic News Network

    ... drug-herb interactions. Laboratory studies have shown that two common chemotherapy drugs used to treat breast cancer ― doxorubicin and cyclophosphamide ...

  10. A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... drugs, surgical procedures or devices. Medical ... For the immunosuppressant therapy treatment group ... Should not be enrolled into the immunosuppressant ...